Latest News in the pharma Industry

Research & Development

MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities

MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities

17 Jul 2016

The charity will now also be able to pursue exciting novel research and development collaborations with new partners.

Read more 
Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer

Lilly and Boehringer Ingelheim announce clinical trial collaboration in metastatic breast cancer

17 Jul 2016

Study to evaluate potential of novel combination therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative (HR+, HER2-) metastatic breast cancer (mBC).

Read more 
Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class

Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class

14 Jul 2016

The collaboration will evaluate the use of Avacta’s Affimer technology in combination with Glythera’s PermaLink conjugation chemistry.

Read more 
EC grants marketing authorization for Gilead’s Epclusa for the treatment of all genotypes of chronic hepatitis C

EC grants marketing authorization for Gilead’s Epclusa for the treatment of all genotypes of chronic hepatitis C

10 Jul 2016

Epclusa is the first and only all-oral, single tablet regimen for all genotypes (1-6) of chronic hepatitis C virus infection and is Gilead’s third Sofosbuvir-based treatment.

Read more 
FDA approves Genentech’s Xolair for allergic asthma in children

FDA approves Genentech’s Xolair for allergic asthma in children

8 Jul 2016

Approval makes Xolair the only biologic for children ages six and up with uncontrolled allergic asthma.

Read more 
EC approves extended indication for Amgen's Kyprolis

EC approves extended indication for Amgen's Kyprolis

4 Jul 2016

Head-to-head Phase III trial demonstrated superiority of Kyprolis and dexamethasone over Velcade and dexamethasone in patients with relapsed multiple myeloma.

Read more 
Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda

Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda

4 Jul 2016

Collaboration combines Merck’s leadership in immuno-oncology with Moderna’s pioneering mRNA vaccine technology and rapid cycle time, small-batch GMP manufacturing capabilities.

Read more 
LEO Pharma enters biologics through strategic partnership with AstraZeneca

LEO Pharma enters biologics through strategic partnership with AstraZeneca

1 Jul 2016

The partnership covers potential new medicines for atopic dermatitis and psoriasis.

Read more 
BMS and PsiOxus Therapeutics announce immuno-oncology clinical collaboration

BMS and PsiOxus Therapeutics announce immuno-oncology clinical collaboration

30 Jun 2016

Companies will evaluate the combination of Opdivo and enadenotucirev to treat a range of tumour types in late-stage cancer patients.

Read more 
BoneAlbumin induces better bone formation

BoneAlbumin induces better bone formation

29 Jun 2016

Positive results in a double-blind controlled study in the knee.

Read more 
GSK's MenABCWY vaccine set to revolutionize meningococcal disease prevention market

GSK's MenABCWY vaccine set to revolutionize meningococcal disease prevention market

29 Jun 2016

Should the MenABCWY vaccine perform well in upcoming Phase III studies, it has the potential to become market leader, says GlobalData.

Read more 
FDA Advisory Committee recommends approval of Jardiance for cardiovascular indication

FDA Advisory Committee recommends approval of Jardiance for cardiovascular indication

29 Jun 2016

Endocrinologic and Metabolic Drugs Advisory Committee votes in favour of cardiovascular mortality benefit for JARDIANCE for adults with type 2 diabetes.

Read more